PlainRecalls
FDA Drug Critical Class I Ongoing

Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18

Reported: January 31, 2024 Initiated: December 21, 2023 #D-0261-2024

Product Description

Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18

Reason for Recall

Presence of particulate matter: glass

Details

Recalling Firm
PFIZER
Units Affected
3,546 vials
Distribution
Nationwide in the USA, Netherlands and Libya
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18. Recalled by PFIZER. Units affected: 3,546 vials.
Why was this product recalled?
Presence of particulate matter: glass
Which agency issued this recall?
This recall was issued by the FDA Drug on January 31, 2024. Severity: Critical. Recall number: D-0261-2024.